Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113 USD | -0.92% |
|
+1.84% | -8.93% |
15/07 | Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating | MT |
12/07 | Stifel Adjusts Price Target on DexCom to $132 From $145 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.93% | 4.49TCr | |
-6.46% | 18TCr | |
-6.43% | 9.88TCr | |
-7.28% | 6.53TCr | |
+15.46% | 4.54TCr | |
+8.19% | 4.38TCr | |
+12.00% | 2.9TCr | |
+19.39% | 2.56TCr | |
-9.09% | 2.33TCr | |
-12.47% | 2.19TCr |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- Transcript : DexCom, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 08